Liver disease risk in chronic hemolytic anemia patients
Part of Blood & lymphatic, Digestive system, Immune system & allergy, Lungs & breathing clinical trials.
This study looks at what makes people with thalassemia or sickle cell anemia more likely to develop liver disease. It aims to find factors that could help prevent or manage liver complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with thalassemia or sickle cell anemia
- You are being seen at the Clinical Hematology unit at Assiut University
- You do not have a history of drinking alcohol heavily
- You do not have a history of cancer
- You do not have a history of autoimmune hepatitis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with advanced chronic liver disease to find ways to predict when they might get worse or develop liver cancer. Researchers hope to use this information to prevent complications and improve care.
This observational study looks at people with thalassemia, sickle cell disease, or other inherited anemia who have COVID-19. It aims to learn how COVID affects these conditions and may help improve care planning.
This study checks how common liver problems are in children with congenital heart disease. It may help doctors better monitor and care for your child's liver health.
This study looks at how blood clotting, inflammation, and blood vessels change in people with chronic liver disease or cirrhosis. Your blood tests may help researchers understand what drives the disease and could guide future care.
This research study evaluates people with liver disease or at risk for liver disease, and compares them with healthy volunteers. The goal is to better understand liver disease and improve how doctors diagnose and treat it.
This study looks at how cancers occur and what they look like in people with certain inherited blood disorders, such as beta-thalassemia, hemoglobin H disease, and sickle cell disease. It may help doctors better understand cancer patterns in these conditions so care can be improved.
Hear when a new Liver Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.